US EditionA Link Between some Weight Loss Drugs and Potentially Blinding Eye Disease
4 Articles
4 Articles
A link between some weight loss drugs and potentially blinding eye disease
For Monday, June 16, WGN’s Ben Bradley and Lourdes Duarte have the latest on new medical information, including: More Coverage: WGN's Medical Watch Study: GLP-1 drugs increase risk for age-related macular degeneration New research suggests a link between some weight loss drugs and potentially blinding eye diseases. That risk is especially high for older adults. A recent study found that older adults with diabetes taking any GLP-1 drug dou…
On Nutrition: Don’t miss the fine print on weight-loss drugs By Barbara Intermill
I hear a lot of talk around our small town when someone becomes noticeably thinner. “He sure has lost a lot of weight.” “Did she have weight loss surgery?” “I hope he’s not sick.”
Gustavo AlonsoSemaglutide, the active substance in the Wegovy and Ozempic medicines, was originally developed to treat type 2 diabetes; however, its effects on weight loss have made it a medical tool for dealing with overweight and obesity cases. In Mexico, where more than 75% of the adult population lives with any of these conditions, the arrival of Wegovy marks a new chapter in the available treatments. The drug is already supported by clinica…
Novo Nordisk to Replace CEO as Rival Weight-Loss Drugs Challenge Ozempic and Wegovy
Novo Nordisk announced plans to replace its chief execu […] The post Novo Nordisk to Replace CEO as Rival Weight-Loss Drugs Challenge Ozempic and Wegovy first appeared on GeneOnline News. The post Novo Nordisk to Replace CEO as Rival Weight-Loss Drugs Challenge Ozempic and Wegovy appeared first on GeneOnline News.
Coverage Details
Bias Distribution
- 100% of the sources are Center
To view factuality data please Upgrade to Premium
